Human respiratory syncytial virus (HRSV) is classified into two major groups
Introduction
Human respiratory syncytial virus (HRSV) has long been recognized as a major cause of serious, life-threatening lower respiratory tract illness in infants and young children (Kim et al., 1973 ; Institute of Medicine, 1985 ; Anderson et al., 1990 ; Hall et al., 1990) , and has also been shown to be an important cause of lower respiratory tract illness in adults (Dowell et al., 1996) . On the basis of monoclonal antibody studies, HRSV has been classified into two major groups, A and B (Mufson et al., 1985 ; Anderson et al., 1985) , and within these groups, antigenic variants or types of HRSV have also been identified (Hendry et al., 1986 ; A H kerlind et al., 1988 ; Mufson et al., 1988 ; Anderson et al., 1991 ; Storch et al., 1991) . Sequence studies of the occurred each year such that no genotype or subtype predominated for more than 1 of the 5 study years. The consistency in the displacement of the predominant strain suggests that a shift, even within the same group, is advantageous to the virus. It was hypothesized that the ' novel ' strain is better able to evade previously induced immunity in the population and consequently either circulates more efficiently or is more pathogenic. The yearly shift in HRSV strains may contribute to the ability of HRSV to consistently cause yearly outbreaks of HRSV disease. These results also suggest that isolates may need to be characterized as to both group and genotype to fully understand protective immunity after natural infection and efficacy studies of candidate vaccines. nucleoprotein (N), phosphoprotein (P), small hydrophobic (SH) protein and attachment (G) protein genes have confirmed the division of HRSV into two groups and also identified numerous variants or lineages within each group (Johnson et al., 1987 b ; , 1995 Cristina et al., 1991 ; Storch et al., 1991 ; Sullender et al., 1991 ; Cane et al., , 1994 Garcia et al., 1994 ; Sanz et al., 1994) .
The HRSV G protein gene has been shown to be the most divergent, both between and within the major HRSV groups, with 67 % similarity at the nucleotide and 53 % similarity at the deduced amino acid levels between group A and B strains (Johnson et al., 1987 b) . The G protein gene encodes a highly glycosylated protein that ranges from 289 to 298 amino acids (Wertz et al., 1985 ; Johnson et al., 1987 b ; Sullender et al., 1991 ; . Variability of the G protein gene primarily occurs in the extracellular domain, which contains two hypervariable regions separated by a 13 amino acid motif (residues 164-176), conserved among all RSV strains (Johnson et al., 1987 b ; Sullender et al., 1991) and considered to be the putative site for virus attachment to the cell receptor (Johnson et al., 1987 b) . The genetic variability of HRSV has been best characterized for group A strains (Cristina et al., 1991 ; , 1995 Garcia et al., 1994 ; Cane et al., 1994 ; Sanz et al., 1994) . Studies have shown up to 20 % diversity at the deduced amino acid level among group A strains and demonstrated that genetically similar strains seem to cluster by time rather than by geographical location (Garcia et al., 1994 ; Sanz et al., 1994 ; Cane & Pringle, 1995a) . These studies suggest that immunological pressure may direct HRSV evolution (Garcia et al., 1994 ; Cane & Pringle, 1995a) . Although these studies have provided important insights into the epidemiology of HRSV strains, the circulation patterns of distinct strains in a single community and simultaneously in different communities have still not been fully characterized.
In this study, we evaluated the genetic diversity of both group A and B HRSV strains by sequencing a variable region of the G protein gene of isolates collected during five consecutive epidemic seasons (1990\91-1994\95) in a single community (Rochester, New York, USA). These data provide a better understanding of the patterns of HRSV strain circulation and the possible importance of strain differences to the consistency of yearly community outbreaks of HRSV disease.
Methods
Virus isolates. The isolates were obtained from children under 3 years of age admitted with lower respiratory tract disease to the University of Rochester Medical Center Annual Inpatient Surveillance Program in Rochester, New York, USA. Isolates were chosen to represent the entire time span of each HRSV season. A total of 204 HRSV isolates, representing 38 % of all HRSV-positive specimens identified during the study period, were sequenced ( Table 1 ). The viruses were isolated in HEp-2 cells at the University of Rochester and propagated once in the same cell line at The Centers for Disease Control and Prevention for sequencing studies.
Antigenic characterization. Monoclonal antibody reactivity patterns based on a previously described capture enzyme immunoassay were used to assign each isolate to group A or B.
Sequencing data sources. Published sequences of the SH, G and F (fusion) protein genes obtained from GenBank and EMBL as well as G gene sequences obtained in our laboratory were used in our studies.
Oligonucleotide primers. Primers complementary to SH, G, and F gene nucleotide sequences were used to amplify (SHA-SHB\F1 ; Table  2 ) and sequence the full-length G gene in selected isolates (SHA, GA1-GA4, F1 for A group ; SHB, GB1-GB4, F1 for B group ; Table 2 ). Primer sets GPA\F1-GSA\F1 and GPB\F1-GSB\F1 (Table 2) were used, respectively, to amplify and sequence the limited region of the G gene for group A and B strain studies.
RT-PCR and nucleotide sequencing. RNA was extracted using a guanidium isothiocyanate-phenol method (RNAzol B, Tel-Test) and (Table 2) at 50 mC for 25 min and reverse-transcribed with avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim) at 42 mC for 1 h. After cDNA synthesis, the PCR assay was carried out in a mix containing up to 5 µl template, 10 µl buffer (150 mM Tris-HCl, 500 mM KCl, 15 mM MgCl # , DMSO 3 %, glycerol 8 %), 20 mM dNTPs, 40 mM of the forward and reverse primers, and 5 U Taq polymerase brought up to 100 µl with distilled water. Amplification conditions consisted of 2 min at 94 mC, followed by 30 cycles of PCR (94 mC for 1 min ; 52 mC for 1 min ; 72 mC for 2 min) and 7 min at 72 mC. The PCR products were purified with either a QIAquick gel extraction kit or a QIAquick PCR purification kit (Qiagen). Both strands were sequenced on ABI 373 or 377 Sequencer models, using a fluorescent dye terminator kit (Applied Biosystems). The nucleotide sequences were edited with SeqEd in the Wisconsin Package version 8.1 (GCG, Madison, Wisconsin, USA) for Unix, or Sequencher version 3.0 (Gene Codes Corporation) for Power Macintosh.
Nucleotide sequencing approach. Multiple alignments of the G gene nucleotide and deduced amino acid sequences were plotted to estimate the average similarities for A and B group sequences, using the ' Multiple Comparison Programs ' in the GCG package. To determine if a limited region of the G gene could serve as a reliable proxy for the entire G gene variability, phylogenetic analysis of sequence alignments encompassing (i) the first variable region (nt 280-459, A and B groups), (ii) the second variable region (nt 649-918, A group ; nt 652-921, B group) and (iii) both variable regions was performed and compared with an analysis conducted with full-length G gene sequences of group A and B viruses (data not shown). Nucleotide numbering was based on the prototype strains A2 and 18537 for A and B groups, respectively (Johnson et al., 1987 b) . The second variable region, consisting of 270 nucleotides, was selected for the subsequent sequencing studies.
Phylogenetic analysis. Nucleotide sequences obtained from the second variable region of the G gene from the 204 HRSV isolates were compiled in multiple alignments, using the GCG program PILEUP. Unique representative sequences for both A and B group viruses were included in the phylogenetic analysis for computational efficiency. In this way, 123 A group and 81 B group sequences were abridged, respectively, in 46 and 21 sequences. Phylogenetic trees were constructed for group A and B alignments, using a maximum likelihood method (DNAML, PHYLIP version 3.5c package ; Felsenstein, 1995) , with transition-totransversion ratio calculated with PUZZLE version 3.1 (Strimmer & von Haeseler, 1996) . Confidence estimates were based on bootstrap resampling carried out with 100 replicates (Felsenstein, 1985) . Trees were plotted using TREEVIEW (Page, 1996) .
Results

Variation in HRSV : A and B genotypes and subtypes
Trees derived from the maximum likelihood reconstruction based on a limited region of the group A and B HRSV G genes are shown in Fig. 1 . To facilitate analysis of the data, sequences were assigned to ' genotypes ' defined by the major clades observed in the tree (Fig. 1) . Phylogenetic analysis of the 46 group A unique sequences identified five clades, assigned as genotypes GA1 to GA5 (Fig. 1 a) . Bootstrap tests of the internal nodes at the interior branches in the tree that characterized the genotypes displayed values of 78-100 %.
A phylogenetic analysis for 21 representative B group sequences showed four clades (GB1 to GB4 ; Fig. 1 b) , supported by 88-100 % of bootstrap replicates. One isolate (140) which was weakly supported at bootstrapping analysis (60 %), did not cluster in any of the four B group genotypes and, therefore, was not considered in the analyses of these four genotypes.
After reviewing the phylogenetic relationships among strains within the genotypes, we further divided closely related strains, based on nucleotide similarity 96 %, into groups that we arbitrarily designated as ' subtypes '. We identified 22 distinct subtypes among the five group A genotypes composed of 123 HRSV sequences. Seventy-three sequences were placed in GA5 ; this genotype comprised half of the group A subtypes (A.5a to A.5k) and presented the greatest intra-genotype nucleotide variability (13 %). GA4 exhibited the least intragenotype nucleotide variability (1 %), with only one subtype (A.4a), composed of five HRSV sequences.
Six subtypes were identified among the four group B genotypes, consisting of 81 HRSV sequences. GB1, represented by one subtype (B.1a), accounted for half of the B group HRSV sequences, while GB2 exhibited one subtype with eight RSV sequences. The intra-genotype nucleotide variability for the B genotypes was quite low, ranging from 1 % (GB1 and GB2) to 3 % (GB3 and GB4).
Variation in HRSV : amino acid sequences
The amino acid sequences deduced from the 270 nucleotide fragment of HRSV A and B G gene sequences were used to generate a consensus sequence in each genotype (Fig. 2) . The predicted amino acid sequences in A genotypes consisted of 86 (GA1-GA4) or 87 residues (GA5). B group genotype sequences showed 83 (GB2-GB4) or 87 (GB1) residues. The difference in the length of the deduced amino acid sequences resulted from first-nucleotide-position mutations in the first stop codon in the carboxyl terminus of the G protein gene. The italicized numbers in square brackets at the main interior branches show the bootstrap replicates supporting the analysis (n l 100). Numbers in parentheses at the terminal nodes correspond to number of identical sequences. Italic bold numbers (a, 1a-5k ; b, 1a-4b) indicate subtypes. Squared boxes are used to associate virus sequences with the corresponding subtype when necessary. Genotypes are indicated by capital letters (GA1-GA5 and GB1-GB4). Branch lengths are not drawn to scale.
Group A strains showed the greatest variation between genotypes in the predicted amino acid sequences, with an average difference of 20 % and a range from 10 % between GA2 and GA3 to 28 % between GA1 and GA4. The average Fig. 2 . Alignment of predicted amino acid consensus sequences for A and B genotypes based on the 270 nucleotide fragment of the G gene. A consensus sequence generated from the genotype consensus amino acid sequences is shown for A and B groups, respectively. Only amino acids that differ from the group consensus sequence are represented. Amino acid positions with two different residues indicate that there was not a consensus for the genotype at that position and both amino acids were represented in equivalent proportion among the studied strains. difference in predicted amino acid difference between group B strains was 13 %, with a range from 7 % (GB2 and GB3) to 19 % (GB1 and GB4).
Certain amino acid substitutions were specific for the genotypes, i.e. every genotype could be distinguished from the others belonging to the same group based on particular amino acid substitutions at different positions along the deduced amino acid motif. For instance, GA1-GA5 could be differentiated by, respectively, Pro%, Ser"*, Pro&*, Pro'', and Thr'$, and GB1-GB4 could be distinguished by Ala$, Pro$&, Pro#&, and Arg$' (Fig. 2) .
Temporal circulation patterns of HRSV group A and B genotypes and subtypes
Several patterns in the temporal distribution of HRSV strains were noted when the strains were analysed in the context of HRSV group, genotype and subtype.
First, the relative ratio of group A and group B strains shifted each year (Fig. 3) , i.e. group B strains predominated during the first and third years, group A strains predominated during the second and fourth years, and A and B group strains were present at nearly equal proportions during the last year. † n l total number of isolates, numbers in brackets indicate identical sequences (subtypes A.2b and B.3a showed two and three distinct groups of identical sequences, respectively). ‡ Percentage applies to the total number of isolates for that year.
Second, multiple genotypes and subtypes circulated each year. Two subtypes from two distinct genotypes circulated during the 1990\91 season, and five (1992\93) to 15 subtypes (1991\92) from four to six genotypes circulated during the remaining four RSV seasons ( Fig. 3 and Table 3 ). Third, despite the multiplicity of subtypes circulating each year, one to two subtypes accounted for more than 50 % of the total number of isolates for the respective year (predominant subtypes) (Table  3 , bold letters). The shift in predominant genotype and subtype each year was of particular interest. In addition to the change in the relative predominance of A and B group strains each year, a shift in genotype and subtype occurred each year such that no one genotype or subtype was among the predominant genotypes or subtypes in more than one of the study seasons. Several genotypes and subtypes, however, were present in multiple seasons. GA5 was identified in each season, GA1 in four of five seasons, and GB3 and GB4 were detected in three seasons (Fig. 3) . Of the 28 group A and B subtypes, seven were present during two seasons, while subtype B.3a was present during three seasons and subtype A.5h during four seasons. The remaining 19 subtypes were present during only one season. Among the 10 predominant subtypes (Table 3) , five were present in one additional season and one (B.3a) was present during two additional seasons.
Identical sequences within some subtypes were seen in multiple years ( Fig. 1 and Table 3 ). One subtype, A.1a isolate (1993\94 season), had a sequence identical to 10 isolates in the following season. Six subtype A.5h isolates (1990\91 season) had a sequence identical to 15 isolates from the 1991\92 and three isolates from the 1993\94 seasons. Fifteen subtype A.5g isolates (1991\92 season) had a sequence identical to two isolates from the 1993\94 season. Among B group strains, 37 subtype B.1a isolates (1990\91 season) had the same sequence as one isolate in the following season.
Discussion
Extensive differences in HRSV strains have been demonstrated previously by different groups studying primarily two RSV membrane proteins, the G protein and the SH protein (reviewed in Cane & Pringle, 1995 b) . Cane et al. (1994) analysed HRSV strain variation in consecutive years in one community on the basis of SH gene sequencing for the A group and N gene restriction analysis for the B group. They observed a shift in the predominant genetic group, circulation of multiple ' lineages ' of HRSV, and emergence of new lineages in the community during the study period. In addition, studies in several communities have shown yearly shifts in relative predominance of group A and B strains (Hall et al., 1990 ; Waris, 1991) . The data obtained in our study provide additional evidence that the occurrence of shifts in HRSV strains is a consistent and probably important feature of the epidemiology of HRSV infections.
Phylogenetic analysis of sequences obtained from the second variable region of the G gene allowed us to identify two levels of relationships between strains within the same group that we arbitrarily designated as genotypes and subtypes. Genotypes probably identify differences between strains within group A or group B most likely to affect antigenic characteristics of these viruses, while subtypes should identify viruses which are antigenically similar.
To place our genotype designation in the context of previously reported studies, we examined the relationships of G gene sequences of the HRSV strains obtained in our study with published G gene sequences described by , Sullender et al. (1991) and Garcia et al. (1994) (dendrograms not shown).
Phylogenetic analysis for A group strains showed that (i) strains 642 and 1734 (United Kingdom ; and Mon-9-91, Mon-9-92, Mon-5-90 and Mon-5-91 (Uruguay ; Garcia et al., 1994) clustered with GA1 strains ; (ii) strains A2 (Australia) and Long (USA) were related to GA1 strains but were distinct from each other and from the other GA1 strains ; (iii) strains Mon-3-88, Mon-1-89 (Uruguay) and Mad-3-89 (Spain) (Garcia et al., 1994) clustered with GA2 strains ; (iv) strains 5857, 6614 and 6256 (United Kingdom ; , Mad-4-91, Mad-3-92 and Mad-5-92 (Spain ; Garcia et al., 1994) clustered with GA3 strains ; and (v) strains represented by , Mon-1-90 and Mon-8-92 (Uruguay) (Garcia et al., 1994) and 6190 (United Kingdom ; grouped with GA5 strains. None of the strains with published G gene sequences clustered with GA4 strains.
Since there are substantially fewer published B group G gene sequences, it was more difficult to define genotype relationships in the context of those sequences. Based on data from Sullender et al. (1991) , we observed that (i) prototype strains 8-60 (Sweden) and 18537 (USA) formed a separate and distinct cluster, (ii) strains 9320 (USA), nm1355 (USA) and wv4843 (West Virginia, USA) were distinct from each other and did not cluster with any of our genotypes, and (iii) strains wv10010 and wv15291 (West Virginia, USA) grouped with GB1 strains.
This analysis highlights the fact that genotype and even subtype are preliminary designations and this, or other approaches, to categorize HRSV strains will probably be modified as additional strain sequence data becomes available.
Genotype and subtype designations have, however, proven to be very helpful in illustrating the multiplicity of strains circulating in Rochester, New York ; the presence of predominant genotypes and subtypes during each HRSV season ; and the shift in the relative proportion of group A and B strains and in the predominant genotype and subtype each year. The consistent shift in predominant genotypes and subtypes is emphasized by the fact that no genotype or subtype predominated for more than one HRSV season and suggests that strain differences either impact the efficiency of circulation or the likelihood that a strain will be isolated. We hypothesize that strain differences affect protective immunity such that a relative lack of immunity in the population to a ' novel ' virus may allow it to transmit more efficiently or be more pathogenic.
A number of studies have demonstrated immunologically important differences between group A and group B viruses (Johnson et al., 1987 a ; Hendry et al., 1988) , but very few studies have looked for immunological differences between strains in the same group, and no study has yet demonstrated such differences to be immunologically important. Two studies of antibody-mediated response induced by natural infection in humans do, however, show that variable regions of the G protein do induce antibodies specific to strains within group A. In these two studies, human antibodies reacted against expressed or synthetically produced peptides from variable regions of the G protein in a strain-specific fashion (Cane et al., 1996 ; Cane, 1997) . We have initiated studies to determine if these ' strain-specific ' G protein antibodies influence which strains cause disease in infants during community RSV outbreaks. Since the G protein is highly glycosylated, it is possible that the immunological impact of amino acid differences between strains is amplified by changes that occur at glycosylation sites (Melero et al., 1997) . Mutations in potential glycosylation sites in the haemagglutinin protein have been shown to provide a selective advantage for influenza virus by either generating virus progeny which are more resistant to neutralization or ' covering ' antigenic sites by the addition of a new glycosylation site (Schulze, 1997) .
In addition to their potential importance to RSV immunity, strain differences have also helped us better understand RSV transmission in hospitals, in communities and globally. Previous studies have identified both community-specific and regional or global features of the epidemiology of HRSV strains. On the basis of monoclonal antibody reaction patterns, one study demonstrated that different communities had distinct patterns of circulating strains during the same year and found no regional or national epidemic strain(s), suggesting that the pattern of outbreak strains is dictated from within the community . Other investigators, using sequencing studies, have identified very similar strains present simultaneously in widely separated geographical regions Garcia et al., 1994) , suggesting that outbreak strains may spread globally. The data from the present study suggest that both community factors and global spread impact circulation of strains in a community. First, the multiplicity of strains and the appearance of strains not previously seen in the community suggest that many strains probably come from outside the community. Second, the potential for G gene sequences to be stable over several years as shown in this study and other studies (Garcia et al., 1994 ; requires that investigators use caution in determining source and links between outbreak strains based on G gene sequences. Thus, isolation of viruses with identical sequences from distant locations indicates a common source but the stability of G gene sequences means that spread from this common source may have occurred over years and not necessarily in an epidemic fashion like that for influenza A virus. We suspect that HRSV strains from all over the world can be introduced into a community, but then local factors, such as population patterns of strain-specific immunity, determine which of these strains circulate efficiently and become ' outbreak strains '.
In summary, our data suggest that the multiplicity and shifting patterns of circulating HRSV strains may be important to the ability of HRSV to consistently cause yearly outbreaks of disease. Additionally, our data suggest that both group and genotype may need to be considered to fully understand protective immunity after natural infection and the results of vaccine efficacy studies.
